GlucoSet
2011
FOUNDED
M&A
STATUS
11-20
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
3
INVESTORS
Description
Developer of health monitoring system designed to reduce harmful hypoglycemia. The company's real-time intravascular blood glucose monitoring system delivers continuous and accurate information on the patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Distributors (Healthcare)
Parent Company
Primary Office
- Sluppenvegen 6
- 7037 Trondheim
- Norway
+47 977 00 000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore GlucoSet’s full profile, request a free trial.
GlucoSet Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Buyout/LBO | Completed | Pre-Clinical Trials | ||||
| 2. Grant | 24-Feb-2016 | 00.000 | Completed | Pre-Clinical Trials | ||
| 1. Grant | 17-Oct-2014 | $24.7K | Completed | Pre-Clinical Trials |
GlucoSet Executive Team (5)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Nicolas Elvemo | Chief Executive Officer | ||
| Parvinder Dhillon | Chief Technology Officer | ||
| Reinold Ellingsen Ph.D | Co-Founder & Board Member | ||
| Dag Hjelme | Co-Founder |
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »GlucoSet Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Erik Fuglseth Ph.D | Self | Board Member | 000 0000 | |
| Jan Sollid | Self | Chairman | 000 0000 | |
| Jørgen Nilsen | Televenture | Board Member | 000 0000 | |
| Kjell Ingebrigtsen Ph.D | Self | Board Member | 000 0000 | |
| Reinold Ellingsen Ph.D | GlucoSet | Co-Founder & Board Member | 000 0000 |